Research focus Evidence Based Medicine & Health Technology Assessment

Head of research focus

Dr. med. Anja Hagen, MPH, Medical Quality Manager

Research Associate

Ricarda Brender
Dr. med. Dr. PH Vitali Gorenoi

Associate employee

Kathrin Krüger, MPH

Brief description

The research focus EBM & HTA has been preparing systematic reviews and HTA reports for various, mainly public clients and funding institutions for many years. After consultation with the client, medical, economic, social, ethical, organizational and legal aspects of the application of a technology are systematically investigated.

In addition, the working group also plays an active role in the preparation of methodological reports in the field of HTA (e.g. analysis of innovation management and various evaluation methods). A particular interest lies in the area of early technology assessment.

The research focus EBM & HTA is a cooperation partner of the DIMDI (German Institute for Medical Documentation and Information) and the IQWiG (Institute for Quality and Efficiency in Health Care) and prepares systematic reviews for the Cochrane Collaboration.

The experience gained from the large number of successfully completed HTA projects is reflected in specific project management, which guarantees both a stringent schedule with adherence to deadlines and a high level of communication with close links to the client.

Current projects

There are currently around four to six HTA projects in progress, which for reasons of confidentiality can only be posted on the website after publication.

The HTA working group is a cooperation partner of the DIMDI (German Institute of Medical Documentation and Information) and the IQWiG (Institute for Quality and Efficiency in Health Care), among others.

Completed projects

  • Ultrasound screening for abdominal aortic aneurysms
  • Measures to promote the health behavior of men
  • Bone replacement materials for treating traumatic fractures of the extremities
  • CT coronary angiography versus conventional invasive coronary angiography in CHD diagnostics
  • Percutaneous coronary interventions in addition to optimal drug therapy for stable angina pectoris
  • Protection against infection in knee endoprosthetics
  • Specific immunotherapy (SIT) for the treatment of allergic rhinitis
  • Methods for the early evaluation of innovative medical technologies during development
  • Joint Endoprostheses Register for Germany
  • Instruments for risk prediction for cardiovascular diseases
  • Drug-eluting stents compared to bypass surgery in coronary artery disease
  • Intravascular brachytherapy for peripheral arterial occlusive disease (PADD)
  • Regulation of the inclusion of innovative non-drug technologies in the range of services of jointly financed cost units
  • Measures to improve compliance or adherence in drug therapy with regard to therapeutic success
  • Benefits and risks of hormonal contraceptives in women
  • Laparoscopic vs. open appendectomy. Systematic overview of medical efficacy and health economic analysis
  • Reduction of restenosis rate through use of coated stents in coronary artery disease
  • Innovation-related technology assessment of cardiovascular implants